Ann: Clinical Trial Contract Expansion & Increases with Bayer AG, page-6

Very nice...Atcor with their Spygmocor technology shows again how important this clinical data and monitoring is for bigger companies the likes of Bayer. Another extension of their trial plus an extra 500.000 in the kitty is a nice validation and how Coops says....importantly, it is this technology - that is trusted by the leading global pharmaceutical companies - THAT FORMS THE BASIS OF OUR COMPETITIVE DIFFERENTIATION as we expand into wearables, smart home devices and OTHER NEW MARKETS.
CDX's devices will be unique, proven, trusted and FDA cleared......a different level than most other existing wearable device makers. Coops vision for penetrating the wearable market from a total different aspect to really deliver something for the greater well being for human kind....exciting times indeed.